Company page

Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation, traded under the ticker ADPT, is a public company based in the United States with a market capitalization of approximately $2.81 billion. The company specializes in leveraging its proprietary technology to decode the adaptive immune system, aiming to improve disease detection and treatment. Adaptive Biotechnologies focuses on applications in areas such as oncology and autoimmune diseases.